Author:
Miyazawa Yuko,Mikami Saki,Yamamoto Keiko,Sakai Masaki,Saito Tatsuya,Yamamoto Tadashi,Ishibashi Kenichi,Sasaki Sei
Funder
Japan Society for the Promotion of Science
Ministry of Health, Labour and Welfare
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference28 articles.
1. Sasaki S. Aquaporins 2: from its discovery to molecular structure and medical implications. Mol Aspects Med. 2012;33:535–46.
2. Radin MJ, Yu MJ, Stoedkilde L, Miller RL, Hoffert JD, Frokiaer J, Pisitkun T, Knepper MA. Aquaporin-2 regulation in health and disease. Vet Clin Pathol. 2012;41:455 – 70.
3. Imamura T, Kinugawa K. Urine aquaporin-2: a promising marker of response to the arginine vasopressin type-2 antagonist, Tolvaptan in patients with congestive heart failure. Int J Mol Sci. 2016;14:17.
4. Nakanishi H, Kurosaki M, Hosokawa T, Takahashi Y, Itakura J, Suzuki S, Yasui Y, Tamaki N, Nakakuki N, Takada H, Higuchi M, Komiyama Y, Yoshida T, Takaura K, Hayashi T, Kuwabara K, Sasaki S, Izumi N. Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites. J Gastroenterol. 2016;51:620–7.
5. Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, Bichet DG, Marumo F. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med. 1995;332:1540–5.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献